In a recent prospective cohort study from the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN), changes in the ALT levels were significantly associated with fibrosis regression in NAFLD (30). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.